Development of an HPLC method with UV detection for the pharmaceutical quality control of the novel marine anticancer agent kahalalide F

Journal of Liquid Chromatography and Related Technologies

Volumn 24, Issue 20, 2001, Pages 3141-3155

  Nuijen, B ^a   Bouma, M ^a   Floriano, P ^b   Manada, C ^b   Rosing, H ^a   Stokvis, E ^a   Bosch, J J Kettenes Van Den ^c   Bult, A ^c   Beijnen, J H ^a  

^a SLOTERVAART HOSPITAL   (Netherlands)

^b PHARMAMAR S A   (Spain)

^c UTRECHT UNIVERSITY   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

DRUG DOSAGE; DRUG PRODUCTS; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; MASS SPECTROMETRY; TUMORS; ULTRAVIOLET DETECTORS;

CALIBRATION CURVES;

CHROMATOGRAPHIC ANALYSIS;

ANTINEOPLASTIC AGENT; CYCLODEPSIPEPTIDE; KAHALALIDE F; UNCLASSIFIED DRUG;

ACCURACY; ANALYTIC METHOD; ARTICLE; CALIBRATION; DRUG DETERMINATION; DRUG DOSAGE FORM; DRUG QUALITY; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; QUALITY CONTROL; ULTRAVIOLET SPECTROSCOPY; VALIDATION PROCESS;

ELYSIA; ELYSIA RUFESCENS; MOLLUSCA; VIOLA (ANGIOSPERM);

EID: 0035211602     PISSN: 10826076     EISSN: None     Source Type: Journal    
DOI: 10.1081/JLC-100107725     Document Type: Article

References (5)

1. Preclinical pharmacology studies with the marine natural product kahalalide F
2. Preclinical development of kahalalide F, a new marine compound selected for clinical studies
3. Pharmaceutical development of a parenteral lyophilized formulation of the novel antitumor agent aplidine
4. Isolation and identification of peptide conformers by reversed-phase high-performance liquid chromatography and NMR at low temperature
5. From the rainforest to the reef: Searching for bioactive natural products in the mid-pacific